Liblomycin
Alternative Names: NK 313Latest Information Update: 07 Feb 1996
At a glance
- Originator Nippon Kayaku
- Class Cytostatic antibiotics; Glycopeptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Feb 1996 The WHO and EphMRA ATC codes for cancer are L01D C and L1D, respectively